FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $447.175M

Company

Location

Date

Amt. (M)

Details

7TM Pharma A/S

Horsholm, Denmark

6/7

DKK123
($22.2)

7TM raised $22.2M in the round led by SR One Ltd., with support from existing investors

Adenosine Therapeutics LLC

Charlottesville, Va.

6/18

$8

Adenosine raised $8M in the first closing of its Series C round, which included an investment from the Novartis Option Fund

Aileron Therapeutics Inc.

Cambridge, Mass.

6/6

$7

Aileron raised $7M through Apple Tree Partners and the Novartis Venture Fund

AlgoNomics NV

Ghent, Belgium

6/20

€2
($2.7)

AlgoNomics raised $2.7M in a round led by Baekland Fund II, and subscribed to by the Gemma Frisius Fund and TrustCapital, as well as the Flanders Institute for Biotechnology, Fortis Private Equity and KBC Private Equity

Aquinox Pharmaceuticals Inc.

Vancouver, British Columbia

6/12

$14.5

Aquinox raised $14.5M in a Series A round led by Ventures West Capital; it included Johnson & Johnson Development Corp., Baker Brothers Investments and BC Advantage Funds

Argolyn Bioscience Inc.

Charleston, S.C.

6/25

$15.8

Argolyn closed a Series A-1 round of $15.8M led by Intersouth Partners and Quaker BioVentures, with participation from Amgen Ventures

Astion Pharma A/S

Copenhagen, Denmark

6/13

DKK50
($8.9)

Astion received $8.9M from existing shareholders

Austrianova Biomanufacturing AG

Vienna, Austria

6/5

€35
($47.3)

Austrianova completed the first closing of its $47.3M financing; funding was provided by Ryan Group Holdings

BioRelix Inc.

New Haven, Conn.

6/8

$25.75

BioRelix completed a Series A round led by CHL Medical Partners; other investors were New Leaf Venture Partners, Aisling Capital, Novartis Venture Fund, Elm Street Ventures and Alexandria Real Estate Equities

BioSurface Engineering Technologies Inc.

Rockville, Md.

6/5

$11

BioSurface completed an $11M equity financing led by PTV Sciences; other investors were Vertical Group, EDF Ventures, MB Ventures and New Markets Growth Fund

Cequent Pharmaceuticals Inc.

Cambridge, Mass.

6/18

$14

Cequent closed a Series A round; investors were Novartis Option Fund, Ampersand Ventures, Nexus Medical Partners and Pappas Ventures

Kiadis Pharma

Amsterdam, the Netherlands

6/26

€15
($20.2)

Kiadis raised $20.2M in a round led by Alta Partners; other investors were Quest for Growth and MedSciences Capital, as well as Life Sciences Partners, Esprit Capital Partners LLP and NV NOM

Koronis Pharmaceuticals Inc.

Seattle

6/28

$20

Koronis raised $20M in a Series D round led by Pacific Horizon Ventures, which was joined by Asset Management Co.

Logical Therapeutics Inc.

Pittsburgh

6/13

$30

Logical Therapeutics raised $30M in a Series B round led by SV Life Sciences, with participation from Burrill & Co., Novo A/S, Sigvion Capital and PA Early Stage Partners

MicuRx Pharmaceuticals Inc.

Union City, Calif.

6/25

$10

MicuRx completed its Series A round with a $10M investment from Morningside Group

OxThera AB

Uppsala, Sweden

6/29

SEK150
($21.9)

OxThera raised $21.9M in a financing round with investors HealthCap, Scandinavian Life Science Venture, Q-Med AB, Industrifonden and a private investor participating

Phytomedics Inc.

Jamesburg, N.J.

6/11

$9

Phytomedics raised $9M in a Series B round; investors included Inventages Venture Capital Investments Inc. and Burrill & Co.

PNP Therapeutics Inc.

Birmingham, Ala.

6/7

$0.925

PNP received $925,000 in a Series B round through the Birmingham Technology Fund, managed by Greer Capital Advisors LLC and Phase 1 Holdings LLC

PolyTherics Ltd.

London

6/27**

£2.3
($4.6)

PolyTherics raised $4.6M in a round led by Longbow Capital LLP

PregLem SA

Geneva

6/27

CHF32
($26)

PregLem raised $26M in a Series A round led by Sofinnova Partners, and co-led by NeoMed Management and MVM Life Science Partners LLP

Probiodrug AG

Halle, Germany

6/25

€20.6
($27.6)

Probiodrug raised $27.6M through a Series A round after completing its merger with Ingenium Pharmaceuticals AG; investors were TVM Capital, HBM BioVentures, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, Sachsen LB Corporate Finance Holding GmbH, tbg Technologiebeteili-gungsgesellschaft, TechnoFonds Bayern, Probiodrug management and Chairman Georg Frank

Profectus BioSciences Inc.

Baltimore

6/15

$3

Profectus completed a $3M private note and warrant placement to investors led by Cross Atlantic Capital Partners and Stewart Greenebaum

Roxro Pharma Inc.

Menlo Park, Calif.

6/12

$42.7

Roxro raised $42.7M in a private placement led by Prospect Venture Partners and Sutter Hill Ventures, with participation from Thomas Weisel Healthcare Venture Partners

Serenex Inc.

Durham, N.C.

6/28

$31

Serenex raised $31M in a Series D round with investments from Cornell Capital Partners, Pearl Street Ventures, MC Life Science Ventures and Pac-Link Bio Venture Capital, as well as Ritchie Capital, Intersouth Partners, Lilly Ventures, Mediphase Venture Partners, Takeda Research Investment and Seaflower Ventures

Singulex Inc.

Hayward, Calif.

6/7

$19.1

Singulex raised $19.1M in a private financing led by OrbiMed Advisors LLC and joined by Fisk Ventures, Prolog Ventures and Advantage Capital

Viamet Pharmaceuticals Inc.

Durham, N.C.

6/8

$4

Viamet raised $4M in a Series A round co-led by Intersouth Partners and Hatteras Venture Partners

Notes:

Currency conversions are based on exchange rates at the time of the deal.

** Denotes the date the item ran in BioWorld International.

ND = Not disclosed.